GLP-1 therapies, or glucagon-like peptide-1 compounds, represent a substantial innovation in how we handle diabetes mellitus . These injectable drugs work by imitating the body’s inherent GLP-1 https://adsbookmark.com/story21809752/glp-1-a-significant-advance-in-diabetes-treatment